Implications of variation in Volume-Regulated Anion Channel composition

容量调节阴离子通道组成变化的影响

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Regulation of cell volume in response to osmotic stress is an essential function of every cell in the body. One well-characterized mechanism for maintaining osmotic balance is the release of Cl- via the Volume-Regulated Anion Channel (VRAC). VRAC is linked to many pathophysiological conditions, in particular, ischemic brain damage and edema during stroke. Normal VRAC activity includes the release of excitatory amino acids (EAAs) and taurine upon cell swelling. However, during a stroke, the release of these compounds contributes to ischemic-induced brain damage. A therapeutic approach that specifically targets neuronal VRAC could be extremely valuable. However, until recently, the identity of VRAC was unknown. Our lab has identified an essential component of VRAC, Swell1 (Leucine-rich-repeat-containing protein 8A, LRRC8A). Although Swell1 is necessary to form VRAC, it is not sufficient; at least one of the other four members of LRRC8 family must be present for normal channel activity. Given that the number and variety of subunits contributing to individual VRAC complexes is currently unknown, a large variety of VRAC compositions may yield functional channels. Tissue-specific differences in LRRC8 subunit expression levels suggest that knowledge of VRAC subunit composition might allow specific therapeutic modulation of VRAC in neuronal tissue. Using advanced membrane protein biochemistry, lipid bilayer electrophysiology to study VRAC function, and single-particle electron microscopy to determine high- resolution structural characteristics, we will investigate the hypothesis that a diverse set of VRAC complexes exist and there are the structural and functional consequences of these variations that could be targeted therapeutically.
 描述(由申请人提供):响应渗透压的细胞体积调节是体内每个细胞的基本功能。维持渗透平衡的一种充分表征的机制是通过体积调节阴离子通道(VRAC)释放Cl-。VRAC与许多病理生理学状况相关,特别是中风期间的缺血性脑损伤和水肿。正常的VRAC活性包括在细胞肿胀时释放兴奋性氨基酸(EAA)和牛磺酸。然而,在中风期间,这些化合物的释放有助于缺血诱导的脑损伤。一种特异性靶向神经元VRAC的治疗方法可能非常有价值。然而,直到最近,VRAC的身份仍然不明。我们的实验室已经确定了VRAC的一个重要组成部分,Swell 1(Leucine-rich-repeat-containing protein 8A,LRRC 8A)。虽然Swell 1是形成VRAC所必需的,但这是不够的; LRRC 8家族的其他四个成员中至少有一个必须存在才能正常的通道活动。考虑到对单个VRAC复合物有贡献的亚基的数量和种类目前是未知的,各种各样的VRAC组合物可以产生功能通道。LRRC 8亚基表达水平的组织特异性差异表明,VRAC亚基组成的知识可能允许神经元组织中VRAC的特异性治疗调节。使用先进的膜蛋白生物化学,脂质双层电生理学研究VRAC功能,和单粒子电子显微镜,以确定高分辨率的结构特征,我们将调查的假设,一个不同的VRAC复合物的集合存在,并有这些变化的结构和功能的后果,可以有针对性的治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer Marie Kefauver其他文献

Jennifer Marie Kefauver的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer Marie Kefauver', 18)}}的其他基金

Implications of variation in Volume-Regulated Anion Channel composition
容量调节阴离子通道组成变化的影响
  • 批准号:
    8981291
  • 财政年份:
    2015
  • 资助金额:
    $ 3.06万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 3.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 3.06万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 3.06万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 3.06万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 3.06万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 3.06万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 3.06万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 3.06万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 3.06万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 3.06万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了